Cite
HARVARD Citation
Loosen, S. et al. (2021). Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysis. JGH open. 5 (3), pp. 356-363. [Online].